The South African Health Products Regulatory Authority (SAHPRA) has cautioned the public against purchasing or using GLP-1 (glucagon-like peptide-1) products that are being promoted and sold on various social media platforms. These products are being promoted to assist with weight loss.
SAHPRA says it has discovered that the sellers of these
products are not based in South Africa, after companies and individuals
illegally marketing GLP-1 products online and falsely claiming to be affiliated
with or authorised by SAHPRA and some of South Africa’s major retail pharmacies.
‘’The products are being shipped from China via post
offices, not from a warehouse in Johannesburg or Cape Town, as stated in the
advertisements. The shipped products are not identical to the advertised
products. SAHPRA has not approved any
oral GLP-1 solution for consumption,’’ said Dr Boitumelo Semete-Makokotlela,
SAHPRA CEO.
‘’SAHPRA urges the public to exercise caution when they are
buying medicines online, from unknown websites or social media pages, as these
medicines may contain dangerous/harmful ingredients that might not be disclosed
to the patients by the seller. Patients should only buy prescribed medicines
from licensed and reputable pharmacies. A list of medicines registered in South
Africa can be found on the SAHPRA website,’’ he added.
SAHPRA further warned that the unauthorised selling,
distribution, or advertising of medicines not registered with SAHPRA is illegal.
“Safeguarding the well-being of the South African public
remains a primary concern for the regulatory authority. SAHPRA is monitoring
the supply chain as well as the online platforms for unregistered, substandard,
and falsified medicines containing or claiming to contain GLP-1 Substances,” said
Semete-Makokotlela.
Members of the public are urged to report any suspicious
medicine sales or false claims of SAHPRA approval. You can report through these
whistleblower platforms, SAHPRA’s 24-hour hotline (0800 204 307)
Done By: Mitchum George

Comments